We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$31.4B
AUM Growth
-$3.29B
(-9.5%)
Cap. Flow
-$3.23B
Cap. Flow
% of AUM
-10.31%
Top 10 Holdings %
Top 10 Hldgs %
14.1%
Holding
3,232
New
197
Increased
1,216
Reduced
1,615
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$16.8M |
| 2 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$11.8M |
| 3 |
Hilton Worldwide
HLT
|
+$9.58M |
| 4 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$7.6M |
| 5 |
WEC Energy
WEC
|
+$6.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$215M |
| 2 |
Microsoft
MSFT
|
+$101M |
| 3 |
ExxonMobil
XOM
|
+$83.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$72.7M |
| 5 |
Johnson & Johnson
JNJ
|
+$68.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.19% |
| 2 | Healthcare | 14.93% |
| 3 | Technology | 14.47% |
| 4 | Industrials | 10.76% |
| 5 | Consumer Discretionary | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
1026
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.66M | 0.01% |
15,160
+4,250
| +39% | +$1.13M |
|
|
WPG
1027
DELISTED
Washington Prime Group Inc.
WPG
| $3.65M | 0.01% |
30,016
+1,081
| +4% | +$143K |
|
1028
CDW
CDW
$18.8B
| $3.65M | 0.01% |
106,517
+39,463
| +59% | +$1.47M |
|
|
BRCD
1029
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $3.65M | 0.01% |
307,146
-15,360
| -5% | -$186K |
|
1030
PRA Group
PRAA
$656M
| $3.65M | 0.01% |
58,544
-3,130
| -5% | -$180K |
|
1031
State Street SPDR S&P 500 ETF Trust
SPY
$789B
| $3.65M | 0.01% |
17,710
-84,175
| -83% | -$17.7M |
|
|
AVP
1032
DELISTED
Avon Products, Inc.
AVP
| $3.63M | 0.01% |
580,719
+17,446
| +3% | +$130K |
|
1033
Silgan Holdings
SLGN
$4.27B
| $3.63M | 0.01% |
137,554
+2,866
| +2% | +$79.4K |
|
|
EQY
1034
DELISTED
Equity One
EQY
| $3.62M | 0.01% |
155,244
+15,270
| +11% | +$383K |
|
1035
Allison Transmission
ALSN
$9.54B
| $3.62M | 0.01% |
123,717
+21,776
| +21% | +$677K |
|
1036
Acadia Healthcare
ACHC
$2.75B
| $3.62M | 0.01% |
46,148
+3,088
| +7% | +$222K |
|
1037
National Health Investors
NHI
$3.69B
| $3.61M | 0.01% |
57,927
+7,500
| +15% | +$501K |
|
1038
AXIS Capital
AXS
$7.72B
| $3.61M | 0.01% |
67,598
-3,363
| -5% | -$181K |
|
1039
White Mountains Insurance
WTM
$5.21B
| $3.6M | 0.01% |
5,499
+1,225
| +29% | +$813K |
|
|
DBD
1040
DELISTED
Diebold Nixdorf Incorporated
DBD
| $3.6M | 0.01% |
102,821
+8,143
| +9% | +$287K |
|
1041
Texas Roadhouse
TXRH
$13.6B
| $3.58M | 0.01% |
95,774
-4,110
| -4% | -$147K |
|
1042
Herbalife
HLF
$1.29B
| $3.58M | 0.01% |
130,102
-1,290
| -1% | -$31.2K |
|
|
ISIL
1043
DELISTED
Intersil Corp
ISIL
| $3.58M | 0.01% |
285,885
+2,625
| +0.9% | +$35.8K |
|
1044
Erie Indemnity
ERIE
$12.5B
| $3.58M | 0.01% |
43,561
+2,928
| +7% | +$242K |
|
1045
Glacier Bancorp
GBCI
$6.38B
| $3.57M | 0.01% |
121,415
-315
| -0.3% | -$8.65K |
|
|
ABMD
1046
DELISTED
Abiomed Inc
ABMD
| $3.57M | 0.01% |
54,303
-770
| -1% | -$51.2K |
|
|
RDC
1047
DELISTED
Rowan Companies Plc
RDC
| $3.57M | 0.01% |
168,912
+2,691
| +2% | +$56.9K |
|
1048
MillerKnoll
MLKN
$1.53B
| $3.56M | 0.01% |
122,976
+2,465
| +2% | +$70.2K |
|
|
ATW
1049
DELISTED
Atwood Oceanics
ATW
| $3.56M | 0.01% |
134,479
+40,961
| +44% | +$1.26M |
|
1050
Kemper
KMPR
$1.67B
| $3.56M | 0.01% |
92,229
-3,325
| -3% | -$126K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2015 Portfolio in Review
As of Q2 2015, RhumbLine Advisers held 3,232 positions worth $31.4B, down 9.5% from $34.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
RhumbLine Advisers withdrew a net $3.23B in Q2 2015, closing 190 positions and reducing 1,615 holdings. Its most notable exit was LORILLARD INC COM STK, an estimated $34M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
Against the trend, RhumbLine Advisers opened a new position in COMCAST CORP SPL A (NEW) worth $11.8M.
- RhumbLine Advisers's largest Q2 2015 buy was COMCAST CORP SPL A (NEW): 197,055 shares worth $11.8M.
- RhumbLine Advisers added most to Aptiv in Q2 2015, an estimated $16.8M increase.
- RhumbLine Advisers's biggest Q2 2015 reduction was Apple, cutting an estimated $215M.
- RhumbLine Advisers fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $34M.
- RhumbLine Advisers's ten largest holdings make up 14% of its $31.4B portfolio in Q2 2015.
- RhumbLine Advisers opened 197 new positions and closed 190 in Q2 2015.
- RhumbLine Advisers's portfolio value fell 9.5% quarter-over-quarter to $31.4B.
Based on RhumbLine Advisers's 13F filing for Q2 2015, filed 4 Aug 2015.